Nusinersen (Spinraza) Last Updated: October 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: Nusinersen Indications: Spinal Muscular Atrophy Brand Name: SpinrazaManufacturer: Biogen Canada Inc.Project Number: SR0576-000Project Status: ActiveSubmission Type: Resubmission Tags Genetics, Nervous System, Pediatrics, Genetics, Musculoskeletal, Nervous system, Pediatrics Details
ertugliflozin and metformin (Segluromet) Last Updated: October 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: ertugliflozin and metformin hydrochloride Indications: Diabetes mellitus, Type 2 Brand Name: SeglurometManufacturer: Merck Canada Inc.Project Number: SR0566-000 Project Status: ActiveSubmission Type: NewCombination Tags Diabetes Mellitus, Diabetes, segluromet; ertugliflozin; metformin; Diabetes; Diabetic Details
ertugliflozin (Steglatro) Last Updated: October 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: ertugliflozin Indications: Diabetes mellitus, Type 2 Brand Name: SteglatroManufacturer: Merck Canada Inc.Project Number: SR0565-000Project Status: ActiveSubmission Type: New Tags Diabetes Mellitus, Diabetes, steglatro; ertugliflozin; Diabetes; Diabetic Details
Blincyto for MRD-positive B-cell precursor ALL Published on: October 16, 2018 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10143 Tags Cancer, Lymphoma Details
insulin glargine (Semglee) Last Updated: October 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: insulin glargine Indications: Diabetes mellitus, Type 1 & 2 Brand Name: SemgleeManufacturer: BGP PHARMA ULCProject Number: SE0589-000Project Status: PendingSubmission Type: New
Unituxin for Neuroblastoma – Details Published on: October 16, 2018 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10154
Ibrance (with Faslodex) for Advanced or Metastatic Breast Cancer – Details Published on: October 16, 2018 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10150
pegfilgrastim (Fulphila ) Last Updated: October 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: pegfilgrastim Indications: Febrile neutropenia in non-myeloid malignancies Brand Name: Fulphila Manufacturer: BGP PHARMA ULCProject Number: SE0588-000 Project Status: PendingSubmission Type: New
telotristat (TBC) Last Updated: October 15, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: Telotristat Indications: carcinoid syndrome Brand Name: TBCManufacturer: Ipsen Biopharmaceuticals Canada Inc. Project Number: SR0580-000 Project Status: ActiveSubmission Type: New Tags Cancer, Cancer Details
lumacaftor/ivacaftor (Orkambi ) Last Updated: October 12, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: lumacaftor/ivacaftor Indications: Cystic Fibrosis, F508del CFTR mutation in patients 6 years and older Brand Name: Orkambi Manufacturer: Vertex Pharmaceuticals (Canada) IncorporatedProject Number: SR0559-000Project Status: CompleteSubmission Type: NewIndication Tags Cystic Fibrosis, Cystic Fibrosis, Cystic Fibrosis, Respiratory, Cystic Fibrosis, ivacaftor; lumacaftor; orkambi; mucoviscidosis Details
